Atreca Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
Good afternoon, everyone. Thanks for joining our next presentation. My name is [Lander]. I'm a research associate at H.C. Wainwright. We're pleased to have you with us today. And it is now my pleasure to introduce our next presenter. Please join me in welcoming Tito Serafini, Chief Strategy Officer and Founder of Atreca, a clinical stage biopharmaceutical company focused on developing cancer immunotherapies.
Tito, welcome. And I'll turn it over to you.
Thank you very much for inviting us today, and I'm very happy to present here today at the H.C. Wainwright Conference. So in the interest of time, I will skip through.
Here's our forward-looking statements disclaimer. The entire presentation I'm using today is available on our website as well, and I will skip through some of the company highlights here in the interest of time to focus on what it is we do, why it works, and what our first view of our pipeline assets to give folks -- give you a very good idea, I hope.
What
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |